Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP/PPP/BMAC in Hip Arthroscopy
NCT06003101Phase 3Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone marrow cell concentrate in acetabular labrum tear, Femoroacetabular impingement (FAI), Chondral defect, osteoarthritis (OA), sponsored by Massachusetts General Hospital. Started Aug 2023; status: recruiting.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
acetabular labrum tearFemoroacetabular impingement (FAI)Chondral defectosteoarthritis (OA)
Beyond the preview
Go deeper on NCT06003101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06003101.